Bayer is a publicly traded, multinational company headquartered in Leverkusen, Germany. Founded over 150 years ago, its core competencies presently lie in the life science fields of health care and agriculture.
The company's life science unit has 3 main divisions, pharmaceuticals, consumer health, and crop science. It also has an animal health unit as well as a corporate functions business services unit. In addition, Bayer has a 60% stake in Currenta, a company offering services for the chemical industry including utility supply, waste management, infrastructure, safety, security, analytics, and vocational training.
In terms of sales, Bayer's pharmaceuticals segment is the largest in the company. The focus of this segment is primarily in the therapeutic areas of cardiology, oncology, gynecology, hematology, and ophthalmology. Principal research centers are located in Germany, United States, Finland, and Norway.
The consumer health division focuses on everyday healthcare, where the company has a portfolio of over 170 brands to treat minor illnesses. The products are in areas such as, digestive health, allergies, skin conditions, pain management, nutritional supplements, and common colds.
Bayer's crop sciences division focuses on delivering solutions to farmers in areas such as crop protection, seeds and traits, as well as digital farming. In June 2018, Bayer completed its acquisition of Monsanto for approximately $63 billion. In connection with regulatory approval processes, the company agreed to divest portions of its businesses to BASF.
The company's animal health unit develops and markets products and solutions for the prevention and treatment of diseases in companion and farm animals. In November 2018, Bayer announced its plan to sell the unit, which is estimated to be worth up to €7 billion, along with several other brands. The move is estimated to result in about 12,000 job cuts worldwide.
Bayer's business services unit is an in-house center for business solutions and business support process of the Bayer Group. Its portfolio ranges from development and implementation of IT-based solutions and design, building and execution of end-to-end process operations to in-house management consulting.
Bayer says it will pay up to US$10.9 billion to settle litigation over the subsidiary Monsanto's weedkiller Roundup, which has faced thousands of lawsuits over claims it causes cancer.
Bayer says it is to spend more than 25 billion euros ($27.22 billion) on research and development at its agriculture unit over the next 10 years.
Reuters reported last September initial plans by Bayer to divest its 60% stake in the chemical park operator, part of a string of assets it has put on the block to slash debt since its $63 billion takeover of Monsanto last year.
Bayer announces that it is planning to invest $5.6 billion over the next 10 years in research on weed control.
Johnson & Johnson and Bayer agree to pay $775 million to settle about 25,000 lawsuits involving the blood thinner Xarelto, which they jointly sell.
Bayer acquires Monsanto for $63 billion.
Debra Lopez Quiat
Dr. Hartmut Klusik
Labor Director, Human Resources, Technology, & Sustainability
President, Consumer Health Division
Innovation & Head of Latin America
President, Crop Science Division & Animal Health Business Unit
Head of Pharmaceuticals Division
Chairman & CEO
CFO & Head of Asia Pacific and North America
Bayer Completes Monsanto Acquisition for $63 Billion
Bayer to cut 12,000 jobs and sell brands